Catalyst Wire Dossier Catalyst Wire Dossier

Vamifeport

vamifeport · Vifor (International) Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Vamifeport, covering 2025-02-18 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis [Phase 2]

See pricing